Europe Blood Screening Market – Industry Trends and Forecast to 2027

  • In Vitro Diagnostics
  • Upcoming Report
  • Jun 2020
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Blood Screening Market By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Next-Generation Sequencing (NGS), Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers),Country (Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe) Industry Trends and Forecast to 2027

Europe Blood Screening Market

Market Analysis and Insights: Europe Blood Screening Market

Blood screening market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing with the CAGR of 8.5% in the above-mentioned forecast period. Increasing prevalence of new pathogens and the growing prevalence of infectious diseases will assist in encouraging the growth of the market.

Increase in the demand for donated blood, rising number of blood donations, and the growing prevalence of infectious diseases will lead to boost the market growth. The technological advancement in the treatment along with the developing economies will additionally heighten numerous opportunities that will commence to the germination of the blood screening market in the above-mentioned forecast period. Lack of using NAT technology in emerging countries, high cost of technology and instruments and emerging alternative technologies are the restraints for blood screening market.

This blood screening market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on Data Bridge Market Research blood screening market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Blood Screening Market Scope and Market Size

Blood screening market is segmented on the basis of products & services, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product & services, the market is segmented into reagents & kits, instruments, software & services
  • On the basis of technology, the market is segmented into nucleic acid test, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assay, next-generation sequencing (NGS) and others
  • On the basis of disease type, the market is segmented into respiratory diseases, diabetes mellitus, oncology, cholesterol, HIV/AIDS, cold & flu, infectious diseases and others
  • On the basis of end user, the market is segmented into hospitals, clinics, diagnostic centers, blood bank and ambulatory surgical centers

Blood Screening Market Country Level Analysis

Blood screening market is segmented on the basis of products & services, technology, disease type and end user as referenced above.

The countries covered in the blood screening market report are the Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and Rest of Europe in Europe.

Germany governs the blood screening industry owing to the fact that there is rise in awareness about blood donation and the presence of high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region.

The country section of the blood screening market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Blood screening market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for blood screening market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the blood screening market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Blood Screening Market Share Analysis

Blood screening market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to blood screening market.

The major players operating in the blood screening market report are Enzo Biochem Inc., Meridian Bioscience, Inc., BD, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., BioMérieux SA, Beckman Coulter, Inc., Abbott, F. Hoffmann-La Roche Ltd, Cepheid, GRIFOLS INTERNATIONAL, S.A., Siemens, Ortho Clinical Diagnostics, Immucor, Inc., Hologic Inc., DiaSorin, GFE, Trinity Biotech, Merck KGaA among other domestic player. Market share data is available for global, North America, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Europe Blood Screening Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES EUROPE BLOOD SCREENING MARKET

TABLE 1 LIST OF PRICES FOR FEW DEVICES TABLE 2 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) TABLE 3 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 4 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 5 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 6 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 7 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 8 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 9 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 10 EUROPE SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 11 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 12 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 13 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 14 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) TABLE 15 EUROPE RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 16 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 17 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 18 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 19 EUROPE WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 20 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 21 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 22 EUROPE ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 23 EUROPE DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 24 EUROPE COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 25 EUROPE CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 26 EUROPE INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 27 EUROPE RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 28 EUROPE HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 29 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 30 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 31 EUROPE DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 32 EUROPE BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 33 EUROPE HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 34 EUROPE CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 35 EUROPE AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) TABLE 36 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) TABLE 37 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 38 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 39 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 40 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 41 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 42 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 43 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 44 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 45 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 46 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 47 EUROPE BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) TABLE 48 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 49 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 50 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 51 GERMANY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 52 GERMANY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 53 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 54 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 55 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 56 GERMANY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 57 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 58 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 59 GERMANY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 60 GERMANY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 61 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 62 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 63 U.K. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 64 U.K. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 65 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 66 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 67 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 68 U.K. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 69 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 70 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 71 U.K. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 72 U.K. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 73 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 74 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 75 FRANCE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 76 FRANCE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 77 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 78 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 79 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 80 FRANCE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 81 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 82 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 83 FRANCE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 84 FRANCE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 85 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 86 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 87 ITALY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 88 ITALY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 89 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 90 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 91 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 92 ITALY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 93 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 94 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 95 ITALY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 96 ITALY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 97 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 98 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 99 SPAIN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 100 SPAIN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 101 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 102 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 103 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 104 SPAIN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 105 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 106 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 107 SPAIN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 108 SPAIN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 109 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 110 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 111 SWITZERLAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 112 SWITZERLAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 113 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 114 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 115 SWITZERLAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 116 SWITZERLAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 117 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 118 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 119 SWITZERLAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 120 SWITZERLAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 121 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 122 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 123 NETHERLANDS ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 124 NETHERLANDS NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 125 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 126 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 127 NETHERLANDS BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 128 NETHERLANDS NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 129 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 130 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 131 NETHERLANDS BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 132 NETHERLANDS BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 133 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 134 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 135 BELGIUM ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 136 BELGIUM NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 137 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 138 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 139 BELGIUM BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 140 BELGIUM NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 141 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 142 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 143 BELGIUM BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 144 BELGIUM BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 145 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 146 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 147 RUSSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 148 RUSSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 149 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 150 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 151 RUSSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 152 RUSSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 153 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 154 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 155 RUSSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 156 RUSSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 157 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 158 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) TABLE 159 TURKEY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 160 TURKEY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) TABLE 161 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) TABLE 162 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) TABLE 163 TURKEY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 164 TURKEY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) TABLE 165 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) TABLE 166 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) TABLE 167 TURKEY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) TABLE 168 TURKEY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) TABLE 169 REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions